Morrison, L.M. , Murata, K., Quilligan, J.J., Jr., Schjeide , O.A. and Freeman. L.: Prevention of atherosclerosis in sub-human primates by chondroitin sulfate A, Circulation Research19: 358, 1966.
2.
Morrison, L.M. , Bernick, S., Alfin-Slater, R.B., Patek, P.R. and Ershoff, B.H.: Inhibition of coronary atherosclerosis in the x-irradiated, cholesterol-fed rat by chondroitin sulfate A, Proc. Soc. Exp. Biol. & Med.123: 904, 1966.
3.
Kurita, H.: Uber den Einfluss des chondroitin-sulfates auf die experimentelle atherosklerose in kaninchen, Med. J. Shinshu University1: 23, 1955.
4.
Ohdoi, S.: A supplementary study of sulfated mucopolysaccharides and experimental atherosclerosis , Tokyo J. Med. Sc.67: 1291, 1959.
5.
Murata, K.: Inhibitory effects of chondroitin polysulfate on lipemia and atherosclerosis in connection with its anticoagulant activity, Naturwissenschaften49: 1, 1962.
6.
Oshima, Y.Yokohari, R., Ohdoi, T., Murata, K., Wago, K., Otsuki, A., Noda. M. and Miyamoto, T.: Clinical and experimental studies on mucopolysaccharides (Mucopolysaccharide and atherosclerosis) in Biochemistry and Medicine of Mucopolysaccharides. Ed. Egami F. and Oshima, Y. p. 259, 1962.
7.
Morrison, L.M. , Quilligan, J.J., Jr., Murata, K., Schjeide, O.A., Freeman, L. and Ershoff, B.H.: Treatment of atherosclerosis with acid mucopolysaccharides, Exp. Med. Surg.25#1: 61, 1967 .
8.
Morrison, L.M. , Rucker, P.G. and Ershoff, B.H.: Prolongation of thrombus-formation in rabbits given chondroitin sulfate A, J. Athero. Res.8: 319, 1968.
9.
Morrison, L.M. : Treatment of coronary arteriosclerotic heart disease with chondroitin sulfate A: Preliminary report, J. Amer. Geriatrics Soc.16#7: 779, 1968.
10.
Robbins, R.C. , Morrison, L.M. and Simpson, C.F.: Effect of chondroitin sulfate A and flavonoids on hypervitaminosis D in rats, Proc. Soc. Exp. Biol. & Med.131#3: 719, 1969.
11.
Morrison, L.M. , Branwood, A.W., Ershoff, B.H., Murata, K., Quilligan, J.J., Jr., Schjeide , O.A., Patek, P.R., Bernick, S., Freeman, L., Dunn, O.J. and Rucker, P.G.: The prevention of coronary arteriosclerotic heart disease with chondroitin sulfate A: preliminary report, Exp. Med. Surg.27#3: 278, 1969.
12.
Morrison, L.M. , Bajwa, G.S. and Ershoff, B.H.: Prolongation of plasma thrombus formation time of dogs administered chondroitin sulfate A and C, Exp. Med. Surg.28: 188. 1970.
13.
Morrison, L.M. : Reduction of ischemic coronary heart disease by chondroitin sulfate A, Angiology22#3: 165, 1971.
14.
Morrison, L.M. , Bajwa, G.S., Alfin-Slater , R.B. and Ershoff, B.H.: Prevention of vascular lesions by chondroitin sulfate A in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing diet, Atherosclerosis . In press.
15.
Morrison, L.M. : Cholesterol metabolism: blood serum cholesterol and ester levels in 200 cases of acute coronary thrombosis. Amer. J. Med. Sci.216: 32, 1948.
16.
Holman, R.L. , McGill, H.C., Jr., Strong, J.P., and Geer, J.C.: The natural history of atherosclerosis. The early aortic lesions seen in New Orleans in the middle of the 20th century . Am. J. Path.34: 209,1958.
17.
Morrison, L.M. , Schjeide, O.A., Quilligan, J.J., Freeman, L. and Murata, K.: Metabolic Parameters of the growth-stimulating effect of chondroitin sulfate A in tissue cultures, Proc. Soc. Exp. Biol. & Med.kk9: 618, 1965.
18.
Chandler, A.B. : In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Lab. Invest.7: 110, 1958.
19.
Morrison, L.M. and Schjeide, O.A.: Coronary heart disease and the acid mucopolysaccharides (glvcosaminoglycans). Charles C. Thomas, Publisher. In press.
20.
Murata, K., Quilligan, J. J., Jr., Morrison, L. M. and Schjeide, O. A.: Unpublished data.
21.
Morrison, L.M. , Rucker, P.G. and Dunn, O.J.: Prolongation of thrombus formation time in angina pectoris by chondroitin sulfate A. Abstract. Circulation Supple. II, 35 & 36: 28, 1967.
22.
Srinivasan, S. and Sawyer, P.N.: The effect of thrombogenic and antithrombogenic drugs on the surface charge characteristics of the blood vessel wall and blood cells, Federation Proc.27: 322, 1968.
23.
Schiller, S.: The isolation of chondroitin sulfuric acid from normal human plasma, Biochem. Biophys. Acta28: 423, 1958.
24.
Meyer, K.: Biochemistry and biology of mucopolysaccharides. Amer. Jour. ofMed.47#5: 664, Nov. 1969.
25.
Kirk, J.E. and Dyrbye, M.: Mucopolysacchardies of human arterial tissue II. Analysis of total isolated mucopolysaccharide material. J. Gerontology12: 23, 1957.
26.
b. Berenson, G.S., Dalferes, E.R., Robin, R. and Strong, J.P.: Mucopolysaccharides and atherosclerosis. In: Evolution of the Atherosclerotic Plaque. R. J. Jones, ed., Chicago Press, p. 144, 1963.
27.
Morrison, L.M. : Reduction of Mortality Rate in Coronary Thrombosis by Low-Cholesterol, Low-Fat Diet. Amer. Heart J.42: 638, 1951.
28.
Morrison, L.M. : A Nutritional Program For Prolongation of Life in Coronary Atherosclerosis. J.A.M.A.159: 1425, 1955 .
29.
Morrison, L.M. : Diet in Coronary Atherosclerosis. J.A.M.A.173: 884, 1960.